Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Almendro

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Journal of Cellular Physiology|May 24, 2011
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2Cristina Mayordomo, Susana García-Recio, Elisabet Ametller, et al.
Cancer Research|January 23, 2014
Genetic and phenotypic diversity in breast tumor metastasesVanessa Almendro, Hee Jung Kim, Yu-Kang Cheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 18, 2011
Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screeningSandra Pérez-Torras, Anna Vidal-Pla, Rosa Miquel, et al.
Cancer Research|July 10, 2007
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonistsGemma Fuster, Sílvia Busquets, Elisabet Ametller, et al.
Plos One|June 22, 2012
Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancersErhan Bilal, Kristen Vassallo, Deborah Toppmeyer, et al.
Frontiers in Cell and Developmental Biology|June 9, 2015
Comparison of methods for the isolation of human breast epithelial and myoepithelial cellsArantzazu Zubeldia-Plazaola, Elisabet Ametller, Mario Mancino, et al.
Molecular Oncology|August 23, 2018
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumorsInga H Rye, Anne Trinh, Anna B Saetersdal, et al.
Cancer Research|March 5, 2016
The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal WomenSung Jin Huh, Hannah Oh, Michael A Peterson, et al.
Cancer Letters|March 18, 2018
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancerPatricia Fernández-Nogueira, Aleix Noguera-Castells, Gemma Fuster, et al.
Biochimica Et Biophysica Acta|April 20, 2007
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophyPaola Costelli, Vanessa Almendro, Maria Teresa Figueras, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Cellular Physiology|May 24, 2011
Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2Cristina Mayordomo, Susana García-Recio, Elisabet Ametller, et al.
Cancer Research|January 23, 2014
Genetic and phenotypic diversity in breast tumor metastasesVanessa Almendro, Hee Jung Kim, Yu-Kang Cheng, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 18, 2011
Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screeningSandra Pérez-Torras, Anna Vidal-Pla, Rosa Miquel, et al.
Cancer Research|July 10, 2007
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonistsGemma Fuster, Sílvia Busquets, Elisabet Ametller, et al.
Plos One|June 22, 2012
Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancersErhan Bilal, Kristen Vassallo, Deborah Toppmeyer, et al.
Frontiers in Cell and Developmental Biology|June 9, 2015
Comparison of methods for the isolation of human breast epithelial and myoepithelial cellsArantzazu Zubeldia-Plazaola, Elisabet Ametller, Mario Mancino, et al.
Molecular Oncology|August 23, 2018
Intratumor heterogeneity defines treatment-resistant HER2+ breast tumorsInga H Rye, Anne Trinh, Anna B Saetersdal, et al.
Cancer Research|March 5, 2016
The Proliferative Activity of Mammary Epithelial Cells in Normal Tissue Predicts Breast Cancer Risk in Premenopausal WomenSung Jin Huh, Hannah Oh, Michael A Peterson, et al.
Cancer Letters|March 18, 2018
Histamine receptor 1 inhibition enhances antitumor therapeutic responses through extracellular signal-regulated kinase (ERK) activation in breast cancerPatricia Fernández-Nogueira, Aleix Noguera-Castells, Gemma Fuster, et al.
Biochimica Et Biophysica Acta|April 20, 2007
Modulations of the calcineurin/NF-AT pathway in skeletal muscle atrophyPaola Costelli, Vanessa Almendro, Maria Teresa Figueras, et al.
Pageof 6